Halama, B. (2014). Nanodose study of the CYP3A paradigm substrate midazolam to evaluate pharmacokinetic linearity of parent drug before and during CYP3A inhibition.
Chicago-Zitierstil (17. Ausg.)Halama, Birte. Nanodose Study of the CYP3A Paradigm Substrate Midazolam to Evaluate Pharmacokinetic Linearity of Parent Drug Before and During CYP3A Inhibition. 2014.
MLA-Zitierstil (9. Ausg.)Halama, Birte. Nanodose Study of the CYP3A Paradigm Substrate Midazolam to Evaluate Pharmacokinetic Linearity of Parent Drug Before and During CYP3A Inhibition. 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.